Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.19
-0.55 (-4.32%)
At close: Oct 29, 2025, 4:00 PM EDT
12.27
+0.08 (0.66%)
After-hours: Oct 29, 2025, 7:00 PM EDT
Ginkgo Bioworks Holdings Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Ginkgo Bioworks Holdings stock has a target of 9.00, which predicts a -26.17% decrease from the current stock price of 12.19.
Price Target: $9.00 (-26.17%)
Analyst Consensus: Strong Sell
* Price targets were last updated on Aug 25, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Ginkgo Bioworks Holdings is "Strong Sell". This means that the analyst believes this stock is likely to have very poor returns in the near future.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Total | 7 | 7 | 7 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Sell Maintains $6 → $9 | Strong Sell | Maintains | $6 → $9 | -26.17% | Aug 25, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $3 → $10 | Strong Buy | Maintains | $3 → $10 | -17.97% | Sep 20, 2024 |
| BTIG | BTIG | Strong Sell Maintains $0.2 → $7 | Strong Sell | Maintains | $0.2 → $7 | -42.58% | Aug 23, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $32 → $12 | Strong Sell | Maintains | $32 → $12 | -1.56% | Jul 9, 2024 |
| BTIG | BTIG | Strong Sell Maintains $20 → $8 | Strong Sell | Maintains | $20 → $8 | -34.37% | Jun 26, 2024 |
Financial Forecast
Revenue This Year
178.85M
from 227.04M
Decreased by -21.23%
Revenue Next Year
204.63M
from 178.85M
Increased by 14.41%
EPS This Year
-5.31
from -10.54
EPS Next Year
-4.39
from -5.31
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 190.1M | 220.5M | |
| Avg | 178.9M | 204.6M | |
| Low | 171.5M | 191.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -16.3% | 23.3% | |
| Avg | -21.2% | 14.4% | |
| Low | -24.5% | 6.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -5.42 | -3.69 | |
| Avg | -5.31 | -4.39 | |
| Low | -5.22 | -4.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.